Tirzepatide · 3 min read
Starter prices describe month one; the 10 mg maintenance rate describes the next several years. Every program's maintenance-dose figure, and the flat-vs-scaled math that separates them.
Starter prices describe month one; the 10 mg maintenance rate describes the next several years. Every program's maintenance-dose figure, and the flat-vs-scaled math that separates them.
The single most predictive number in tirzepatide pricing is not the advertised price. It is the all-in monthly cost at your maintenance dose — for most people, 10 mg or above — because that is the rate you will pay for years after the four-month titration ends. Programs know most shoppers compare advertised prices, which is why the market splits into flat-rate programs that publish one honest number and dose-scaled programs whose entry price quietly doubles as an escalator.
At the 10 mg all-in basis in our verified feed: NexLife holds the floor at $215, flat from 2.5 to 15 mg, so its maintenance price is its advertised price. Yucca follows at $258 (a six-month-plan rate). Then the membership pair: IVIM at $278 all-in ($203 medication plus a mandatory $75 membership) and Mochi at $278 ($199 plus $79). ShedRx reaches $289 at tier from a $199 entry. Found's month-to-month is $289 flat. SkinnyRx sits at $299 flat, Henry Meds and TrimRx at $349, Lavender Sky around $352 all-in at tier, Fridays at $359 (third-party), MEDVi and Remedy at $399, Eden at $408 all-in, and LifeMD's split billing lands near $597. On the brand side, Zepbound's maintenance-dose rate is $449 through LillyDirect regardless of whether you settled at 7.5, 10, 12.5, or 15 mg.
Take a typical journey — four months titrating (2.5, 5, 7.5, 10) and eight months holding 10 mg. On flat-rate NexLife, that first year costs twelve times $215: $2,580, no arithmetic required. On dose-scaled ShedRx, the same year runs roughly $199 twice, then the intermediate tiers, then $289 for the balance — a first year near $3,200 whose monthly rate ends 45% above where it started. Scaled programs are not dishonest — the pricing is published — but the comparison shoppers actually make (advertised versus advertised) systematically flatters them. Our flat-rate provider list isolates the programs where the number you see is the number you keep paying, and the pricing database carries first-year totals computed on the maintenance basis for every program.
Before subscribing anywhere, get written answers to: What is the all-in monthly price at 10 mg and at 12.5 mg, including every mandatory fee? Does the price change at any dose on the ladder? Is the advertised figure a promotional, prepaid, or starter rate — and what is the standing month-to-month number? A program that answers all three plainly is telling you something as valuable as the price itself.
Most settle between 10 mg and 15 mg, which is why we rank at the 10 mg all-in basis. A meaningful minority maintain well at 5–7.5 mg, where scaled programs cost less.
In our database, verified first-year totals at the maintenance basis run from $2,580 (NexLife) to $7,164 (LifeMD) for compounded programs; brand Zepbound's first year via LillyDirect runs about $5,188 on a standard titration (one month each at $299 and $399, then $449).